Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 47.4% – Time to Buy?

by · The Cerbat Gem

Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) rose 47.4% during mid-day trading on Saturday . The stock traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares were traded during mid-day trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.

Voyageur Pharmaceuticals Stock Performance

The company has a market cap of C$19.53 million, a price-to-earnings ratio of -14.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The firm’s 50-day moving average price is C$0.08 and its 200 day moving average price is C$0.06.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Read More